Cyclops
Disposable dry powder inhaler
Cyclops
Disposable dry powder inhaler
Cyclops™ is an easy-to-use, pre-filled, disposable DPI that is developed for inhalation powders and can be produced in a cost-effective way because of its simple yet sophisticated proprietary design.
Upon inhalation it uses the patient’s breath to disperse the dry powder formulation into small particles appropriately sized for deep lung deposition. Cyclops™ has several advantages compared to standard-of-care DPIs across key therapeutic areas. These attributes enable the hygienic and effective use on a worldwide scale. One product, Colistin Cyclops™, is already marketed and reimbursed under a named patient regimen for the treatment of cystic fibrosis patients.
HIGHLY PREFERRED BY PATIENTS
Latest news
QA officer
Locatie: Roden, Nederland Omvang: 0.4-0.6fte In verband met de uitbreiding
PureIMS gears up for abbreviated registration of Levodopa Cyclops® against OFF episodes in Parkinson’s disease with the successful completion of a comparative pharmacokinetic study
Roden, the Netherlands, January 18, 2024 PureIMS, a pharmaceutical company
PureIMS winning the LIFE Science Innovation Award!
Tuesday September 26 was an exciting day for the PureIMS team. Not
PureIMS initiates dose-finding study with Levodopa Cyclops™ dry powder inhaler
Following a successful funding round in April of this year